Empowering appropriate antimicrobial use with rapid diagnostics.

The Problem

Clostridium difficile infection (CDI) is commonly associated with prior exposure to broad- spectrum antibiotics that compromise a patient's normal gut flora, allowing C. difficile to proliferate and cause toxin-mediated disease. This can proceed to serious, life-threatening conditions such as Pseudomembranous Colitis (PMC).